tert-Butyl (3R,4S)-rel-3-hydroxy-4-methylpiperidine-1-carboxylate
98%
- Product Code: 113254
CAS:
374794-75-9
| Molecular Weight: | 215.29 g./mol | Molecular Formula: | C₁₁H₂₁NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD18791214 | |
| Melting Point: | Boiling Point: | 301.4±35.0 °C(Predicted) | |
| Density: | 1.067±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C, inert gas |
Product Description:
This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of chiral molecules. Its stereochemistry makes it valuable in constructing complex structures for drugs targeting neurological and cardiovascular conditions. It is often employed as a building block in asymmetric synthesis, enabling the creation of enantiomerically pure compounds. Additionally, it serves as a key precursor in the production of biologically active molecules, contributing to the advancement of medicinal chemistry research. Its stability and reactivity also make it suitable for use in organic transformations, facilitating the development of novel therapeutic agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿2,340.00 |
+
-
|
| 1.000 | 10-20 days | ฿7,020.00 |
+
-
|
| 5.000 | 10-20 days | ฿17,550.00 |
+
-
|
tert-Butyl (3R,4S)-rel-3-hydroxy-4-methylpiperidine-1-carboxylate
This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of chiral molecules. Its stereochemistry makes it valuable in constructing complex structures for drugs targeting neurological and cardiovascular conditions. It is often employed as a building block in asymmetric synthesis, enabling the creation of enantiomerically pure compounds. Additionally, it serves as a key precursor in the production of biologically active molecules, contributing to the advancement of medicinal chemistry research. Its stability and reactivity also make it suitable for use in organic transformations, facilitating the development of novel therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :